基本信息
views: 39

Bio
I’m a RNA biologist, analytical chemist and drug developer who is working to bring life-changing drugs from bench-to-bedside. I build platforms to discover and validate radically different science-based, analytics-driven, drug targets. While simultaneously providing the regulatory frameworks required to expedite approval of these therapeutics and meet safety and efficacy requirements.
As a creative problem solver, I enjoy generating out-of-the- box ideas that create value and opportunities. I seek the adrenaline rush of having an epiphany.
My strength lies in developing solutions which address unmet medical needs and complex scientific problems. As a scientist, I discovered fundamental properties of genetic coding that enabled pathogens to survive hostile environments; the principles of which are currently used to understand cellular behavior across multiple fields from cancer to biologics production.
As a drug developer, I formulated and executed strategies on rapid response to infectious diseases, by bringing three antiviral therapeutic antibodies to clinical trials within months of discovery.
I believe the current pandemic-driven tech revolution will allow us to proactively create systems that rapidly diagnose diseases, design cures, and treat patients whenever, and wherever, it is needed.
As a creative problem solver, I enjoy generating out-of-the- box ideas that create value and opportunities. I seek the adrenaline rush of having an epiphany.
My strength lies in developing solutions which address unmet medical needs and complex scientific problems. As a scientist, I discovered fundamental properties of genetic coding that enabled pathogens to survive hostile environments; the principles of which are currently used to understand cellular behavior across multiple fields from cancer to biologics production.
As a drug developer, I formulated and executed strategies on rapid response to infectious diseases, by bringing three antiviral therapeutic antibodies to clinical trials within months of discovery.
I believe the current pandemic-driven tech revolution will allow us to proactively create systems that rapidly diagnose diseases, design cures, and treat patients whenever, and wherever, it is needed.
Research Interests
Papers共 26 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Communications Biologyno. 1 (2024)
Jenny G. Low, Justin H. J. Ng,Eugenia Z. Ong,Shirin Kalimuddin,Limin Wijaya,Yvonne F. Z. Chan,Dorothy H. L. Ng,Hwee-Cheng Tan, Anjali Baglody,Yok-Hian Chionh, Debbie C. P. Lee,Yadunanda Budigi,Ram Sasisekharan,Eng-Eong Ooi
Load More
Author Statistics
#Papers: 26
#Citation: 1255
H-Index: 19
G-Index: 23
Sociability: 5
Diversity: 3
Activity: 0
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn